Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03654417 · ClinicalTrials.gov registry record · Phase 4
Pain Perception During Vulvar Biopsy
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 37
- Enrollment target
NCT03654417 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 37 participants.
The verdict
NCT03654417, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to compare pain control during vulvar biopsy following either (1) application of EMLA (a eutectic mixture of local anesthetics lidocaine 2.5% and prilocaine 2.5%) cream or (2) injection of 1% lidocaine. We hypothesize that lidocaine will provide better biopsy analgesia, but the benefit will be offset by the pain of lidocaine injection compared to EMLA application, thus there will not be a significant difference in highest pain scores between the two groups.
Interventions
- DRUG Lidocaine
- DRUG EMLA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2018-09-17 |
| Est. Completion | 2019-03-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03654417
The ClinicalTrials.gov registry entry for NCT03654417 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lidocaine is the first listed.
NCT03654417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03654417 about?
NCT03654417 is a clinical study titled "Pain Perception During Vulvar Biopsy". The purpose of this study is to compare pain control during vulvar biopsy following either (1) application of EMLA (a eutectic mixture of local anesthetics lidocaine 2.5% and prilocaine 2.5%) cream or (2) injection of 1% lidocaine. We hypothesize that lidocaine will provide better biopsy analgesia, ...
What is the current status of trial NCT03654417?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 37 participants. The study started on 2018-09-17. Estimated completion is 2019-03-12.
What interventions are being tested in trial NCT03654417?
The interventions under investigation include: Lidocaine (DRUG), EMLA (DRUG).
Who is sponsoring clinical trial NCT03654417?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.